These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 75547)

  • 21. Natural anti-tumor serum reactivity in BALB/c mice. II. Control by regulator T-cells.
    Colnaghi MI; Ménard S; Porta GD
    Int J Cancer; 1977 Feb; 19(2):275-80. PubMed ID: 300078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural anti-tumor serum reactivity in BALB/c mice. I. Characterization and interference with tumor growth.
    Ménard S; Colnaghi MI; Porta GD
    Int J Cancer; 1977 Feb; 19(2):267-74. PubMed ID: 300077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.
    Williams WH; Krueger RG
    J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products.
    Lemonnier F; Burakoff SJ; Mescher M; Dorf ME; Benacerraf B
    J Immunol; 1978 May; 120(5):1717-20. PubMed ID: 307020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity.
    Blank KJ; Lilly F
    Nature; 1977 Oct; 269(5631):808-9. PubMed ID: 73137
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation.
    Lesley J; Hyman R; Dennert G
    J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238
    [No Abstract]   [Full Text] [Related]  

  • 28. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the activity of cytotoxic murine T lymphocytes by antibodies to idiotypic determinants.
    Rabinowitz R; Schlesinger M
    Immunology; 1980 Jan; 39(1):93-9. PubMed ID: 6155324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal molecular requirements for reactivity of tumor cells with T cells.
    Hale AH; Lyles DS; Paulus LK; Ruebush MJ
    J Immunol; 1980 May; 124(5):2063-70. PubMed ID: 6245133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of cytotoxic T-cell reactivity to syngeneic tumors by the thymus.
    Reinisch CL; Andrew SL
    J Exp Med; 1978 Aug; 148(2):619-23. PubMed ID: 308983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk.
    Gooding LR
    J Immunol; 1982 Sep; 129(3):1306-12. PubMed ID: 6286762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1979 Jun; 122(6):2328-36. PubMed ID: 221583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific recognition of the product of a transferred major histocompatibility complex gene by cytotoxic T lymphocytes.
    Woodward JG; Orn A; Harmon RC; Goodenow RS; Hood L; Frelinger JA
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3613-7. PubMed ID: 6980415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.
    Perry LL; Dorf ME; Benacerraf B; Greene MI
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):920-4. PubMed ID: 106399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloantisera reacting with tumor cells of inappropriate haplotype. I. Characterization of target antigens.
    Prat M; Rogers MJ; Appella E
    J Natl Cancer Inst; 1978 Aug; 61(2):527-34. PubMed ID: 79659
    [No Abstract]   [Full Text] [Related]  

  • 39. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
    Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
    Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.